Cardiac Inflammation Research Group
11 – 20 of 31
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction. Reply
(
- Contribution to journal › Letter
-
Mark
Short-term S100A8/A9 Blockade Promotes Cardiac Neovascularization after Myocardial Infarction
2024) In Journal of Cardiovascular Translational Research(
- Contribution to journal › Article
-
Mark
Special Issue “COVID-19 Coagulopathy: Advances on Pathophysiology and Therapies”
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation
(
- Contribution to journal › Article
-
Mark
A study of size-selective renal elimination using a novel human model
(
- Contribution to journal › Article
-
Mark
Elevated carbohydrate antigen 125 (CA125) is associated with incident heart failure and mortality in acute coronary syndrome
(
- Contribution to journal › Article
-
Mark
Mechanistic and therapeutic studies in cardiac inflammation
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Increasing plasma calprotectin (S100A8/A9) is associated with 12-month mortality and unfavourable functional outcome in critically ill COVID-19 patients
(
- Contribution to journal › Article
-
Mark
Shedding of membrane complement inhibitors CD59 and CD46 into the circulation is associated with poor prognosis in acute coronary syndrome patients : a cohort study
(
- Contribution to journal › Article
-
Mark
Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function : a pre-specified quality of life sub-study from the REDUCE-AMI trial
(
- Contribution to journal › Article